Stock comparison

INSMvsNTRA

Insmed IncvsNatera Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

INSM

Insmed Inc

$144.48

-26.63%

Biotechnology$35.0BNASDAQ

NTRA

Natera Inc

$201.14

-11.94%

Biotechnology$28.0BNASDAQ

60-day price, rebased to 100

INSM -8.45% · NTRA -13.11%

Round-by-round

INSM 2·NTRA 4

EdgeNTRA

Valuation upside

-90.50% vs -67.20% to DCF fair value

EdgeNTRA

Balance-sheet strength

Altman Z 9.81 vs 23.91

EdgeNTRA

Fundamental quality

Piotroski 4.00 vs 5.00 (of 9)

EdgeNTRA

Growth + margins

Rule-of-40 -92.80 vs 39.20

EdgeINSM

60-day momentum

-8.45% vs -13.11% price return

EdgeINSM

Market-cap liquidity

$35.0B vs $28.0B

Verdict

Across6categories,NTRAtakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onINSMorNTRA

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.